$449 Million is the total value of Ghost Tree Capital, LLC's 43 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 71.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | New | INVESCO QQQ TRput | $31,374,000 | – | 100,000 | +100.0% | 6.99% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $30,024,000 | +378.6% | 1,350,000 | +217.6% | 6.69% | +269.0% |
| TRILLIUM THERAPEUTICS INC | $28,685,000 | +3.5% | 1,950,000 | 0.0% | 6.39% | -20.2% | ||
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $27,420,000 | +199.9% | 500,000 | +25.0% | 6.11% | +131.2% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $23,200,000 | +22.6% | 500,000 | -13.0% | 5.17% | -5.5% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $18,590,000 | – | 325,000 | +100.0% | 4.14% | – |
| CNST | Sell | CONSTELLATION PHARMCETICLS I | $18,000,000 | +22.5% | 625,000 | -13.8% | 4.01% | -5.5% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $17,512,000 | -12.7% | 105,000 | -19.2% | 3.90% | -32.7% |
| ARVN | Buy | ARVINAS INC | $17,411,000 | +268.7% | 205,000 | +2.5% | 3.88% | +184.2% |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $15,966,000 | -18.3% | 600,000 | -42.9% | 3.56% | -37.0% |
| FATE | Sell | FATE THERAPEUTICS INC | $15,003,000 | +87.7% | 165,000 | -17.5% | 3.34% | +44.7% |
| IMVT | Sell | IMMUNOVANT INC | $13,857,000 | -25.0% | 300,000 | -42.9% | 3.09% | -42.2% |
| FOLD | AMICUS THERAPEUTICS INC | $13,854,000 | +63.5% | 600,000 | 0.0% | 3.09% | +26.1% | |
| TGTX | Buy | TG THERAPEUTICS INC | $13,005,000 | +143.0% | 250,000 | +25.0% | 2.90% | +87.3% |
| TVTX | New | TRAVERE THERAPEUTICS INC | $12,946,000 | – | 475,000 | +100.0% | 2.88% | – |
| COGT | New | COGENT BIOSCIENCES INC | $12,353,000 | – | 1,100,000 | +100.0% | 2.75% | – |
| MRTX | New | MIRATI THERAPEUTICS INCcall | $10,982,000 | – | 50,000 | +100.0% | 2.45% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $10,982,000 | +10.2% | 50,000 | -16.7% | 2.45% | -15.0% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $10,766,000 | +199.2% | 700,000 | +115.4% | 2.40% | +130.7% |
| KURA | Buy | KURA ONCOLOGY INC | $10,615,000 | +54.0% | 325,000 | +44.4% | 2.36% | +18.7% |
| ISEE | Buy | IVERIC BIO INC | $9,501,000 | +68.5% | 1,375,000 | +37.5% | 2.12% | +29.9% |
| SURF | SURFACE ONCOLOGY INC | $9,240,000 | +33.9% | 1,000,000 | 0.0% | 2.06% | +3.3% | |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $8,505,000 | – | 500,000 | +100.0% | 1.90% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $6,820,000 | -25.3% | 40,000 | -38.5% | 1.52% | -42.4% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $6,705,000 | +0.1% | 900,000 | -53.8% | 1.49% | -22.8% |
| HLXA | New | HELIX ACQUISITION CORP | $5,685,000 | – | 500,000 | +100.0% | 1.27% | – |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $5,670,000 | +12.8% | 810,000 | +0.6% | 1.26% | -13.1% |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $4,734,000 | – | 2,440,000 | +100.0% | 1.06% | – |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $4,459,000 | -51.9% | 650,000 | -48.0% | 0.99% | -62.9% |
| ACRS | New | ACLARIS THERAPEUTICS INC | $4,206,000 | – | 650,000 | +100.0% | 0.94% | – |
| IMUX | IMMUNIC INC | $4,052,000 | -17.7% | 265,000 | 0.0% | 0.90% | -36.5% | |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $3,798,000 | -13.8% | 200,000 | -42.9% | 0.85% | -33.6% |
| MRNA | New | MODERNA INCput | $3,656,000 | – | 35,000 | +100.0% | 0.82% | – |
| CRIS | New | CURIS INC | $3,481,000 | – | 425,000 | +100.0% | 0.78% | – |
| SRRA | New | SIERRA ONCOLOGY INC | $3,206,000 | – | 200,000 | +100.0% | 0.71% | – |
| CTIC | New | CTI BIOPHARMA CORP | $2,415,000 | – | 750,000 | +100.0% | 0.54% | – |
| MLND | MILLENDO THERAPEUTICS INC | $1,980,000 | +31.3% | 925,000 | 0.0% | 0.44% | +1.1% | |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $1,956,000 | +364.6% | 400,000 | +300.0% | 0.44% | +257.4% |
| APVO | New | APTEVO THERAPEUTICS INC | $1,833,000 | – | 50,000 | +100.0% | 0.41% | – |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $1,574,000 | -56.4% | 200,000 | -52.9% | 0.35% | -66.3% |
| OTIC | New | OTONOMY INC | $1,294,000 | – | 200,000 | +100.0% | 0.29% | – |
| STSA | SATSUMA PHARMACEUTICALS INC | $922,000 | +18.5% | 200,000 | 0.0% | 0.20% | -8.9% | |
| BIIB | Sell | BIOGEN INC | $539,000 | -54.7% | 2,200 | -47.6% | 0.12% | -65.1% |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -4,500 | -100.0% | -0.07% | – |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -125,000 | -100.0% | -0.08% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.18% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -10,000 | -100.0% | -0.20% | – |
| GRAY | Exit | GRAYBUG VISION INC | $0 | – | -75,000 | -100.0% | -0.28% | – |
| IMV | Exit | IMV INC | $0 | – | -325,000 | -100.0% | -0.42% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -135,000 | -100.0% | -0.42% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -75,000 | -100.0% | -0.60% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -200,000 | -100.0% | -0.76% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -30,000 | -100.0% | -0.84% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -250,000 | -100.0% | -1.02% | – |
| NXTC | Exit | NEXTCURE INC | $0 | – | -400,000 | -100.0% | -1.02% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -115,000 | -100.0% | -1.07% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -825,000 | -100.0% | -1.20% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -175,000 | -100.0% | -1.77% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -550,000 | -100.0% | -2.34% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -1,161,375 | -100.0% | -3.46% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -451,000 | -100.0% | -14.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.